Background: Abnormal SPECT myocardial perfusion imaging (SPECT-MPI) denotes obstructive coronary artery disease (CAD) and is predictive of cardiovascular events. Conversely, a normal scan is associated with a low short-term risk. An abnormal SPECT-MPI has been shown to lead to enhanced medical therapy and patients’ adherence. We hypothesized that a normal SPECT-MPI, in subjects without known CAD, would lead to a decrease in preventive therapy.
Methods: a retrospective cohort study that included all subjects without known CAD, that had their first SPECT-MPI scan at Soroka-Medical-Center between 1997-2008. Baseline characteristics, prescription retrieval of aspirin and a statin from the HMO pharmacy within 1 year from SPECT-MPI, and health status, were retrieved from the central database of Clalit-Health-Services. Medication non-adherence was defined as <50% retrieval. We compared subjects with normal scan (summed stress score - SSS<2) vs. abnormal scan. Parsimonious cox regression model was utilized to assess multiple variables associated with increased risk of myocardial infarction and cardiac mortality within 8 years after SPECT-MPI and with 1-year drug cessation.
Results: 11,642 subjects had a normal SPECT-MPI, and in comparison to subjects with abnormal scan (n=6892) were predominantly female (56.6% vs. 24.7%,p<0.001), at younger age (64.1±11.2 vs. 65.4±10.8,p<0.001) and were less likely to be smokers (13.2% vs. 15.5%, p<0.001). Statin and aspirin use at 1-year period post-scan were both increased in the study group in comparison to the pre-scan period (50.6% vs. 41.5% pre-scan for statin, and 49.6% vs. 41.5% for aspirin, p